Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Ptc Therapeutics (PTCT) Other Operating Expenses (2017 - 2025)

Ptc Therapeutics (PTCT) has 11 years of Other Operating Expenses data on record, last reported at $800000.0 in Q1 2025.

  • For Q1 2025, Other Operating Expenses rose 700.0% year-over-year to $800000.0; the TTM value through Dec 2025 reached $800000.0, down 82.12%, while the annual FY2025 figure was $800000.0, 82.12% down from the prior year.
  • Other Operating Expenses reached $800000.0 in Q1 2025 per PTCT's latest filing, down from $10.2 million in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $128.9 million in Q2 2023 and bottomed at -$10.8 million in Q3 2021.
  • Average Other Operating Expenses over 5 years is $9.4 million, with a median of $100000.0 recorded in 2024.
  • The widest YoY moves for Other Operating Expenses: up 11800.0% in 2022, down 152.07% in 2022.
  • A 5-year view of Other Operating Expenses shows it stood at $12.1 million in 2021, then tumbled by 152.07% to -$6.3 million in 2022, then soared by 142.86% to $2.7 million in 2023, then surged by 276.85% to $10.2 million in 2024, then plummeted by 92.14% to $800000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Other Operating Expenses were $800000.0 in Q1 2025, $10.2 million in Q4 2024, and -$700000.0 in Q3 2024.